Immunotherapy for Colon Cancer
A physician-evaluated, immune-based approach for patients diagnosed with colon or colorectal cancer.
Colon Cancer: Overview
Colon cancer is commonly treated with surgery, chemotherapy, radiation, targeted therapy, or immunotherapy depending on the stage and molecular profile. Many patients continue looking for additional options — especially when the disease is advanced, recurrent, metastatic, or when conventional treatment has affected quality of life.
NK Cell Immunotherapy offers a cellular approach designed to support the immune system's natural ability to identify and respond to abnormal cells.
"NK cells can recognize stressed or abnormal cells through multiple signals — a quality that makes them particularly relevant in colorectal cancer."
Giostar Medical Team
Why early action is Critical
Colon cancer can progress silently — many patients are diagnosed only after the disease has advanced.
u.s. deaths - 2026 est.
55,230
leading cause of cancer death in the United States — for both men and women.
cancer death ranking
#2
most common cause of cancer death in the U.S. when men and women and combined
Advanced disease may affect
Digestion and nutrition
Energy and weight
Pain levels
Independence and mobility
Delaying action may reduce available options and allow the disease to become harder to manage.
Why Consider Cellular Immunotherapy?
Natural Killer cells are part of the innate immune system and play an important role in immune surveillance. Unlike some immune therapies that depend on specific tumor markers, NK cells can recognize stressed or abnormal cells through multiple activating signals.
Nk cell mechanism
How Natural Killer Cells Target Cancer
Tumor Cell
Cancer cells evade normal immune detection
NK Recognition
NK cells detect "missing self" signals on abnormal cells
Cytotoxic Release
NK cells deploy perforin and granzymes
Cell Elimination
Tumor cell undergoes targeted aproptosis
In the clinical program, NK cells are collected from the patient, expanded in a controlled laboratory setting, and reinfused under physician oversight — supporting the body's own immune targeting capacity.
NK Cell Therapy is designed to:
Support immune surveillance
Help the immune system recognize abnormal cells
Provide a systemic, whole-body immune approach
Complement a broader treatment strategy when medically appropriate
Are You a Candidate?
NK Cell Immunotherapy may be considered for patients who:
Have been diagnosed with breast cancer (any stage, subject to evaluation)
Are exploring complementary or alternative treatment options
Have advanced, recurrent, or metastatic disease
Have not responded as expected to conventional treatment
Want to support immune function during or after treatment
Are seeking a less invasive cellular therapy option
Every case is individually reviewed by our physician team to determine whether the patient is eligible.
Not all colon cancer patients qualify for our program. Eligibility is determined individually through physician-led medical review. This page provides general educational context — not medical advice or a determination of suitability.
A Comprehensive Approach
Physician-led case review
In-house cellular laboratory processing
Nutritional support
International patient coordination
Clinical process
How the Process Works
Medical Evaluation
Your diagnosis, medical history, and treatment goals are reviewed by our physicians.
Immune Profiling & Blood Collection
A blood sample is collected to isolate immune cells and assess baseline function.
NK Cell Expansion
NK cells are activated and expanded in our specialized laboratory.
Controlled Reinfusion
Expanded NK cells are administered intravenously under clinical protocols.
Monitoring & Follow-Up
Progress is tracked through advanced laboratory testing and physician follow-up.
Next Step: Medical Review
If you or a family member has been diagnosed with breast cancer and is exploring additional options, the first step is to submit your case for physician review. Our team will assess your specific situation and respond with an eligibility determination.